Lazzarino M - Search Results

1

The impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis.

Ricci F, Tedeschi A, Vismara E, Greco A, Montillo M, Nichelatti M, Varettoni M, Lazzarino M, Morra E. Ricci F, et al. Among authors: lazzarino m. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):124-6. doi: 10.3816/CLML.2011.n.027. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21454211

2

Clinical characteristics and outcome of immunoglobulin M-related disorders.

Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, Filippini D, Lazzarino M, Morra E. Cesana C, et al. Among authors: lazzarino m. Clin Lymphoma. 2005 Mar;5(4):261-4. doi: 10.3816/clm.2005.n.012. Clin Lymphoma. 2005. PMID: 15794861

3

Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.

Morra E, Cesana C, Klersy C, Barbarano L, Miqueleiz S, Varettoni M, Lucchesini C, Ricci F, Lazzarino M. Morra E, et al. Among authors: lazzarino m. Clin Lymphoma. 2005 Mar;5(4):265-9. doi: 10.3816/clm.2005.n.013. Clin Lymphoma. 2005. PMID: 15794862

4

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.

Tedeschi A, Benevolo G, Varettoni M, Battista ML, Zinzani PL, Visco C, Meneghini V, Pioltelli P, Sacchi S, Ricci F, Nichelatti M, Zaja F, Lazzarino M, Vitolo U, Morra E. Tedeschi A, et al. Among authors: lazzarino m. Cancer. 2012 Jan 15;118(2):434-43. doi: 10.1002/cncr.26303. Epub 2011 Jul 5. Cancer. 2012. PMID: 21732338 Free article. Clinical Trial.

5

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M. Morra E, et al. Among authors: lazzarino m. Leukemia. 2004 Sep;18(9):1512-7. doi: 10.1038/sj.leu.2403442. Leukemia. 2004. PMID: 15322559

6

Risk of second cancers in Waldenström macroglobulinemia.

Varettoni M, Tedeschi A, Arcaini L, Pascutto C, Vismara E, Orlandi E, Ricci F, Corso A, Greco A, Mangiacavalli S, Lazzarino M, Morra E. Varettoni M, et al. Among authors: lazzarino m. Ann Oncol. 2012 Feb;23(2):411-5. doi: 10.1093/annonc/mdr119. Epub 2011 Apr 27. Ann Oncol. 2012. PMID: 21525403 Free article.

7

Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.

Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M; Hematology/Oncology Studies and Trials (HOST) Group, Italy. Morra E, et al. Among authors: lazzarino m. Semin Oncol. 2003 Apr;30(2):172-7. doi: 10.1053/sonc.2003.50068. Semin Oncol. 2003. PMID: 12720131

8

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma.

Lazzarino M, Orlandi E, Montillo M, Tedeschi A, Pagnucco G, Astori C, Corso A, Brusamolino E, Simoncini L, Morra E, Bernasconi C. Lazzarino M, et al. Ann Oncol. 1999 Jan;10(1):59-64. doi: 10.1023/a:1008376728894. Ann Oncol. 1999. PMID: 10076723 Free article. Clinical Trial.

9

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy.

Corso A, Mangiacavalli S, Barbarano L, Montalbetti L, Mazzone A, Fava S, Varettoni M, Zappasodi P, Morra E, Lazzarino M. Corso A, et al. Among authors: lazzarino m. Leuk Res. 2008 Jul;32(7):1085-90. doi: 10.1016/j.leukres.2007.11.011. Epub 2007 Dec 21. Leuk Res. 2008. PMID: 18096226

10

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma.

Corso A, Barbarano L, Mangiacavalli S, Spriano M, Alessandrino EP, Cafro AM, Pascutto C, Varettoni M, Bernasconi P, Grillo G, Carella AM, Montalbetti L, Lazzarino M, Morra E. Corso A, et al. Among authors: lazzarino m. Leuk Lymphoma. 2010 Feb;51(2):236-42. doi: 10.3109/10428190903452826. Leuk Lymphoma. 2010. PMID: 20001242 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters